Perpetual Ltd
RPRX icon

Perpetual Ltd’s Royalty Pharma RPRX Stock Holding History

Perpetual Ltd’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$517K Sell
8,855
-45
-0.5% -$2.66K 0.01% 304
2026
Q2 		$499K Sell
8,900
-60
-0.7% -$3.12K 0.01% 327
2026
Q1 		$430K Hold
8,960
– – 0.01% 340
2025
Q4 		$346K Buy
+8,960
New +$342K 0.01% 356

Other funds holding RPRX

Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Achmea Investment Management
Achmea Investment Management Zeist, Netherlands $12.6B AUM 25.68% 1-Year Est. Return
Eastern Bank
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Perpetual Ltd's RPRX Position: Q3 2026 in Review

Perpetual Ltd reduced its Royalty Pharma (RPRX) stake by 0.51% in Q3 2026, selling an estimated $2.66K and leaving 8,855 shares worth $517K. The position accounts for 0.01% of the portfolio, ranked #304.

Perpetual Ltd first reported a position in RPRX in Q4 2025 and has held it in 4 quarters since. 270 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Perpetual Ltd held 8,855 shares of Royalty Pharma worth $517K as of Q3 2026.
  • Perpetual Ltd sold 45 Royalty Pharma shares in Q3 2026, an estimated $2.66K.
  • Royalty Pharma made up 0.01% of Perpetual Ltd's portfolio in Q3 2026, its #304 holding.
  • Perpetual Ltd first reported a position in Royalty Pharma in Q4 2025 and has held it in 4 quarters since.
  • 270 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Perpetual Ltd's 13F filing for Q3 2026, filed 13 Oct 2026.